-
2
-
-
84886091627
-
Virus-like particle-based human vaccines: Quality assessment based on structural and functional properties
-
This review article summarizes the long journey of the three commercial subviral particle vaccines from bench to patients. The physical properties and structural features of the three VLP vaccines are analyzed. The authors also summarize how the crucial quality attributes of VLP-based human vaccines against diseases were assessed, controlled, and improved during bioprocessing through an array of structural and functional analyses
-
Zhao Q, Li S, Yu H, Xia N, Modis Y: Virus-like particle-based human vaccines: quality assessment based on structural and functional properties. Trends Biotechnol 2013, 31:654-663. This review article summarizes the long journey of the three commercial subviral particle vaccines from bench to patients. The physical properties and structural features of the three VLP vaccines are analyzed. The authors also summarize how the crucial quality attributes of VLP-based human vaccines against diseases were assessed, controlled, and improved during bioprocessing through an array of structural and functional analyses.
-
(2013)
Trends Biotechnol
, vol.31
, pp. 654-663
-
-
Zhao, Q.1
Li, S.2
Yu, H.3
Xia, N.4
Modis, Y.5
-
3
-
-
20144372894
-
A bacterially expressed particulate hepatitis E vaccine: Antigenicity, immunogenicity and protectivity on primates
-
DOI 10.1016/j.vaccine.2004.11.064
-
Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, Ge SX, Xian YL, Pang SQ, Ng MH et al.: A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005, 23:2893-2901. (Pubitemid 40386491)
-
(2005)
Vaccine
, vol.23
, Issue.22
, pp. 2893-2901
-
-
Li, S.W.1
Zhang, J.2
Li, Y.M.3
Ou, S.H.4
Huang, G.Y.5
He, Z.Q.6
Ge, S.X.7
Xian, Y.L.8
Pang, S.Q.9
Ng, M.H.10
Xia, N.S.11
-
4
-
-
55249104282
-
Noroviral P particle: Structure, function and applications in virus-host interaction
-
Tan M, Fang P, Chachiyo T, Xia M, Huang P, Fang Z, Jiang W, Jiang X: Noroviral P particle: structure, function and applications in virus-host interaction. Virology 2008, 382:115-123.
-
(2008)
Virology
, vol.382
, pp. 115-123
-
-
Tan, M.1
Fang, P.2
Chachiyo, T.3
Xia, M.4
Huang, P.5
Fang, Z.6
Jiang, W.7
Jiang, X.8
-
5
-
-
78751706360
-
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles
-
Tan M, Fang PA, Xia M, Chachiyo T, Jiang W, Jiang X: Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology 2011, 410:345-352.
-
(2011)
Virology
, vol.410
, pp. 345-352
-
-
Tan, M.1
Fang, P.A.2
Xia, M.3
Chachiyo, T.4
Jiang, W.5
Jiang, X.6
-
6
-
-
27644437147
-
The P domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors
-
DOI 10.1128/JVI.79.22.14017-14030.2005
-
Tan M, Jiang X: The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol 2005, 79:14017-14030. (Pubitemid 41552700)
-
(2005)
Journal of Virology
, vol.79
, Issue.22
, pp. 14017-14030
-
-
Tan, M.1
Jiang, X.2
-
7
-
-
0033696899
-
Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16
-
Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC: Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 2000, 5:557-567.
-
(2000)
Mol Cell
, vol.5
, pp. 557-567
-
-
Chen, X.S.1
Garcea, R.L.2
Goldberg, I.3
Casini, G.4
Harrison, S.C.5
-
8
-
-
84878343467
-
Hepatitis E virus capsid protein assembles in 4 M urea in the presence of salts
-
Yang C, Pan H, Wei M, Zhang X, Wang N, Gu Y, Du H, Zhang J, Li S, Xia N: Hepatitis E virus capsid protein assembles in 4 M urea in the presence of salts. Protein Sci 2013, 22 :314-326.
-
(2013)
Protein Sci
, vol.22
, pp. 314-326
-
-
Yang, C.1
Pan, H.2
Wei, M.3
Zhang, X.4
Wang, N.5
Gu, Y.6
Du, H.7
Zhang, J.8
Li, S.9
Xia, N.10
-
9
-
-
78650633210
-
Norovirus P particle, a novel platform for vaccine development and antibody production
-
This is a typical study showing the pattern of how a subviral particle is developed into a vaccine platform for antigen display for novel vaccine development
-
Tan M, Huang P, Xia M, Fang PA, Zhong W, McNeal M, Wei C, Jiang W, Jiang X: Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol 2011, 85:753-764. This is a typical study showing the pattern of how a subviral particle is developed into a vaccine platform for antigen display for novel vaccine development.
-
(2011)
J Virol
, vol.85
, pp. 753-764
-
-
Tan, M.1
Huang, P.2
Xia, M.3
Fang, P.A.4
Zhong, W.5
McNeal, M.6
Wei, C.7
Jiang, W.8
Jiang, X.9
-
10
-
-
0027050013
-
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
-
DOI 10.1073/pnas.89.24.12180
-
Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 1992, 89:12180-12184. (Pubitemid 23004809)
-
(1992)
Proceedings of the National Academy of Sciences of the United States of America
, vol.89
, Issue.24
, pp. 12180-12184
-
-
Kirnbauer, R.1
Booy, F.2
Cheng, N.3
Lowy, D.R.4
Schiller, J.T.5
-
11
-
-
77953028997
-
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
-
Jagu S, Kwak K, Garcea RL, Roden RB: Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection. Vaccine 2010, 28:4478-4486.
-
(2010)
Vaccine
, vol.28
, pp. 4478-4486
-
-
Jagu, S.1
Kwak, K.2
Garcea, R.L.3
Roden, R.B.4
-
12
-
-
8444249386
-
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial
-
DOI 10.1016/S0140-6736(04)17398-4, PII S0140673604173984
-
Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS et al.: Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004, 364 :1757-1765. (Pubitemid 39488060)
-
(2004)
Lancet
, vol.364
, Issue.9447
, pp. 1757-1765
-
-
Harper, D.M.1
Franco, E.L.2
Wheeler, C.3
Ferris, D.G.4
Jenkins, D.5
Schuind, A.6
Zahaf, T.7
Innis, B.8
Naud, P.9
De Carvalho, N.S.10
Roteli-Martins, C.M.11
Teixeira, J.12
Blatter, M.M.13
Korn, A.P.14
Quint, W.15
Dubin, G.16
-
13
-
-
20944448032
-
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial
-
DOI 10.1016/S1470-2045(05)70101-7, PII S1470204505701017
-
Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M et al.: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005, 6:271-278. (Pubitemid 40590263)
-
(2005)
Lancet Oncology
, vol.6
, Issue.5
, pp. 271-278
-
-
Villa, L.L.1
Costa, R.L.R.2
Petta, C.A.3
Andrade, R.P.4
Ault, K.A.5
Giuliano, A.R.6
Wheeler, C.M.7
Koutsky, L.A.8
Malm, C.9
Lehtinen, M.10
Skjeldestad, F.E.11
Olsson, S.-E.12
Steinwall, M.13
Brown, D.R.14
Kurman, R.J.15
Ronnett, B.M.16
Stoler, M.H.17
Ferenczy, A.18
Harper, D.M.19
Tamms, G.M.20
Yu, J.21
Lupinacci, L.22
Railkar, R.23
Taddeo, F.J.24
Jansen, K.U.25
Esser, M.T.26
Sings, H.L.27
Saah, A.J.28
Barr, E.29
more..
-
14
-
-
0021238117
-
Human hepatitis B vaccine from recombinant yeast
-
McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR: Human hepatitis B vaccine from recombinant yeast. Nature 1984, 307:178-180. (Pubitemid 14132908)
-
(1984)
Nature
, vol.307
, Issue.5947
, pp. 178-180
-
-
McAleer, W.J.1
Buynak, E.B.2
Maigetter, R.Z.3
-
15
-
-
0023217653
-
Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine
-
Andre FE, Safary A: Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine. Postgrad Med J 1987, 63(Suppl 2):169-177.
-
(1987)
Postgrad Med J
, vol.63
, Issue.SUPPL. 2
, pp. 169-177
-
-
Andre, F.E.1
Safary, A.2
-
16
-
-
84865328748
-
First HEV vaccine approved
-
Proffitt A: First HEV vaccine approved. Nat Biotechnol 2012, 30:300.
-
(2012)
Nat Biotechnol
, vol.30
, pp. 300
-
-
Proffitt, A.1
-
17
-
-
84872034033
-
Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development
-
Wu PC, Lin WL, Wu CM, Chi JN, Chien MS, Huang C: Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Appl Microbiol Biotechnol 2012, 95:1501-1507.
-
(2012)
Appl Microbiol Biotechnol
, vol.95
, pp. 1501-1507
-
-
Wu, P.C.1
Lin, W.L.2
Wu, C.M.3
Chi, J.N.4
Chien, M.S.5
Huang, C.6
-
18
-
-
44249105901
-
Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses
-
Kekarainen T, Montoya M, Dominguez J, Mateu E, Segales J: Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses. Vet Immunol Immunopathol 2008, 124:41-49.
-
(2008)
Vet Immunol Immunopathol
, vol.124
, pp. 41-49
-
-
Kekarainen, T.1
Montoya, M.2
Dominguez, J.3
Mateu, E.4
Segales, J.5
-
19
-
-
83155182848
-
Norovirus vaccine against experimental human Norwalk Virus illness
-
This paper reported the first phase II clinical trials of norovirus VLP vaccine and demonstrated for the first time that norovirus VLP vaccine protects vaccinees against norovirus infection and illness
-
Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C et al.: Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011, 365:2178-2187. This paper reported the first phase II clinical trials of norovirus VLP vaccine and demonstrated for the first time that norovirus VLP vaccine protects vaccinees against norovirus infection and illness.
-
(2011)
N Engl J Med
, vol.365
, pp. 2178-2187
-
-
Atmar, R.L.1
Bernstein, D.I.2
Harro, C.D.3
Al-Ibrahim, M.S.4
Chen, W.H.5
Ferreira, J.6
Estes, M.K.7
Graham, D.Y.8
Opekun, A.R.9
Richardson, C.10
-
20
-
-
0034885747
-
Perspectives of vaccination against hepatitis E
-
Safary A: Perspectives of vaccination against hepatitis E. Intervirology 2001, 44 :162-166.
-
(2001)
Intervirology
, vol.44
, pp. 162-166
-
-
Safary, A.1
-
21
-
-
33847358278
-
Safety and efficacy of a recombinant hepatitis E vaccine
-
DOI 10.1056/NEJMoa061847
-
Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK et al.: Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007, 356:895-903. (Pubitemid 46339908)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.9
, pp. 895-903
-
-
Shrestha, M.P.1
Scott, R.M.2
Joshi, D.M.3
Mammen Jr., M.P.4
Thapa, G.B.5
Thapa, N.6
Myint, K.S.A.7
Fourneau, M.8
Kuschner, R.A.9
Shrestha, S.K.10
David, M.P.11
Seriwatana, J.12
Vaughn, D.W.13
Safary, A.14
Endy, T.P.15
Innis, B.L.16
-
23
-
-
74949121478
-
From the circumsporozoite protein to the RTS, S/AS candidate vaccine
-
This review article summarizes the development process of the first subviral particle based-malaria vaccine from bench to patients. This includes the rational selection of the circumsporozoite protein (CSP) as the target antigen, the genesis of the RTS,S/AS concept, and the salient results of phase 2 studies
-
Cohen J, Nussenzweig V, Nussenzweig R, Vekemans J, Leach A: From the circumsporozoite protein to the RTS, S/AS candidate vaccine. Hum Vaccin 2010, 6:90-96. This review article summarizes the development process of the first subviral particle based-malaria vaccine from bench to patients. This includes the rational selection of the circumsporozoite protein (CSP) as the target antigen, the genesis of the RTS,S/AS concept, and the salient results of phase 2 studies.
-
(2010)
Hum Vaccin
, vol.6
, pp. 90-96
-
-
Cohen, J.1
Nussenzweig, V.2
Nussenzweig, R.3
Vekemans, J.4
Leach, A.5
-
24
-
-
84871037616
-
A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants
-
Rts SCTP, This paper reported the results of the latest phase III clinical trial of the first subviral particle based malaria vaccine, RTS,S/AS01. The vaccine provided modest protection against both clinical and severe malaria in young infants
-
Rts SCTP, Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, Adegnika AA, Mordmuller B, Issifou S et al.: A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N Engl J Med 2012, 367:2284-2295. This paper reported the results of the latest phase III clinical trial of the first subviral particle based malaria vaccine, RTS,S/AS01. The vaccine provided modest protection against both clinical and severe malaria in young infants.
-
(2012)
N Engl J Med
, vol.367
, pp. 2284-2295
-
-
Agnandji, S.T.1
Lell, B.2
Fernandes, J.F.3
Abossolo, B.P.4
Methogo, B.G.5
Kabwende, A.L.6
Adegnika, A.A.7
Mordmuller, B.8
Issifou, S.9
-
25
-
-
0036892173
-
A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts
-
DOI 10.1128/IAI.70.12.6860-6870.2002
-
Birkett A, Lyons K, Schmidt A, Boyd D, Oliveira GA, Siddique A, Nussenzweig R, Calvo-Calle JM, Nardin E: A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect Immun 2002, 70:6860-6870. (Pubitemid 35387919)
-
(2002)
Infection and Immunity
, vol.70
, Issue.12
, pp. 6860-6870
-
-
Birkett, A.1
Lyons, K.2
Schmidt, A.3
Boyd, D.4
Oliveira, G.A.5
Siddique, A.6
Nussenzweig, R.7
Calvo-Calle, J.M.8
Nardin, E.9
-
26
-
-
7044254906
-
Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes
-
DOI 10.1128/IAI.72.11.6519-6527.2004
-
Nardin EH, Oliveira GA, Calvo-Calle JM, Wetzel K, Maier C, Birkett AJ, Sarpotdar P, Corado ML, Thornton GB, Schmidt A: Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes. Infect Immun 2004, 72:6519-6527. (Pubitemid 39425433)
-
(2004)
Infection and Immunity
, vol.72
, Issue.11
, pp. 6519-6527
-
-
Nardin, E.H.1
Oliveira, G.A.2
Calvo-Calle, J.M.3
Wetzel, K.4
Maier, C.5
Birkett, A.J.6
Sarpotdar, P.7
Corado, M.L.8
Thornton, G.B.9
Schmidt, A.10
-
27
-
-
0032874490
-
A universal influenza A vaccine based on the extracellular domain of the M2 protein
-
DOI 10.1038/13484
-
Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999, 5:1157-1163. (Pubitemid 29474420)
-
(1999)
Nature Medicine
, vol.5
, Issue.10
, pp. 1157-1163
-
-
Neirynck, S.1
Deroo, T.2
Saelens, X.3
Vanlandschoot, P.4
Jou, W.M.5
Fiers, W.6
-
28
-
-
59649090229
-
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys
-
Fu TM, Grimm KM, Citron MP, Freed DC, Fan J, Keller PM, Shiver JW, Liang X, Joyce JG: Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys. Vaccine 2009, 27:1440-1447.
-
(2009)
Vaccine
, vol.27
, pp. 1440-1447
-
-
Fu, T.M.1
Grimm, K.M.2
Citron, M.P.3
Freed, D.C.4
Fan, J.5
Keller, P.M.6
Shiver, J.W.7
Liang, X.8
Joyce, J.G.9
-
29
-
-
58149116926
-
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
-
De Filette M, Martens W, Smet A, Schotsaert M, Birkett A, Londono-Arcila P, Fiers W, Saelens X: Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. Vaccine 2008, 26:6503-6507.
-
(2008)
Vaccine
, vol.26
, pp. 6503-6507
-
-
De Filette, M.1
Martens, W.2
Smet, A.3
Schotsaert, M.4
Birkett, A.5
Londono-Arcila, P.6
Fiers, W.7
Saelens, X.8
-
30
-
-
19444368726
-
Universal influenza A vaccine: Optimization of M2-based constructs
-
DOI 10.1016/j.virol.2005.04.004, PII S0042682205002114
-
De Filette M, Min Jou W, Birkett A, Lyons K, Schultz B, Tonkyro A, Resch S, Fiers W: Universal influenza A vaccine: optimization of M2-based constructs. Virology 2005, 337 :149-161. (Pubitemid 40725448)
-
(2005)
Virology
, vol.337
, Issue.1
, pp. 149-161
-
-
De Filette, M.1
Jou, W.M.2
Birkett, A.3
Lyons, K.4
Schultz, B.5
Tonkyro, A.6
Resch, S.7
Fiers, W.8
-
31
-
-
29544452649
-
The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection
-
DOI 10.1016/j.vaccine.2005.08.061, PII S0264410X05008789
-
De Filette M, Ramne A, Birkett A, Lycke N, Lowenadler B, Min Jou W, Saelens X, Fiers W: The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection. Vaccine 2006, 24:544-551. (Pubitemid 43017819)
-
(2006)
Vaccine
, vol.24
, Issue.5
, pp. 544-551
-
-
De Filette, M.1
Ramne, A.2
Birkett, A.3
Lycke, N.4
Lowenadler, B.5
Min, J.W.6
Saelens, X.7
Fiers, W.8
-
32
-
-
70349967937
-
M2e-based universal influenza A vaccine
-
Fiers W, De Filette M, El Bakkouri K, Schepens B, Roose K, Schotsaert M, Birkett A, Saelens X: M2e-based universal influenza A vaccine. Vaccine 2009, 27:6280-6283.
-
(2009)
Vaccine
, vol.27
, pp. 6280-6283
-
-
Fiers, W.1
De Filette, M.2
El Bakkouri, K.3
Schepens, B.4
Roose, K.5
Schotsaert, M.6
Birkett, A.7
Saelens, X.8
-
33
-
-
65449185906
-
Universal M2 ectodomain-based influenza A vaccines: Preclinical and clinical developments
-
Schotsaert M, De Filette M, Fiers W, Saelens X: Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines 2009, 8:499-508.
-
(2009)
Expert Rev Vaccines
, vol.8
, pp. 499-508
-
-
Schotsaert, M.1
De Filette, M.2
Fiers, W.3
Saelens, X.4
-
34
-
-
49649104752
-
A vaccine against nicotine for smoking cessation: A randomized controlled trial
-
Cornuz J, Zwahlen S, Jungi WF, Osterwalder J, Klingler K, van Melle G, Bangala Y, Guessous I, Muller P, Willers J et al.: A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS ONE 2008, 3:e2547.
-
(2008)
PLoS ONE
, vol.3
-
-
Cornuz, J.1
Zwahlen, S.2
Jungi, W.F.3
Osterwalder, J.4
Klingler, K.5
Van Melle, G.6
Bangala, Y.7
Guessous, I.8
Muller, P.9
Willers, J.10
-
35
-
-
22544431937
-
A therapeutic vaccine for nicotine dependence: Preclinical efficacy, and phase I safety and immunogenicity
-
DOI 10.1002/eji.200526285
-
Maurer P, Jennings GT, Willers J, Rohner F, Lindman Y, Roubicek K, Renner WA, Muller P, Bachmann MF: A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity. Eur J Immunol 2005, 35:2031-2040. (Pubitemid 41015042)
-
(2005)
European Journal of Immunology
, vol.35
, Issue.7
, pp. 2031-2040
-
-
Maurer, P.1
Jennings, G.T.2
Willers, J.3
Rohner, F.4
Lindman, Y.5
Roubicek, K.6
Renner, W.A.7
Muller, P.8
Bachmann, M.F.9
-
36
-
-
33845362874
-
A vaccine for hypertension based on virus-like particles: Preclinical efficacy and phase I safety and immunogenicity
-
DOI 10.1097/HJH.0b013e32800ff5d6, PII 0000487220070100000011
-
Ambuhl PM, Tissot AC, Fulurija A, Maurer P, Nussberger J, Sabat R, Nief V, Schellekens C, Sladko K, Roubicek K et al.: A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J Hypertens 2007, 25:63-72. (Pubitemid 44885665)
-
(2007)
Journal of Hypertension
, vol.25
, Issue.1
, pp. 63-72
-
-
Ambuhl, P.M.1
Tissot, A.C.2
Fulurija, A.3
Maurer, P.4
Nussberger, J.5
Sabat, R.6
Nief, V.7
Schellekens, C.8
Sladko, K.9
Roubicek, K.10
Pfister, T.11
Rettenbacher, M.12
Volk, H.-D.13
Wagner, F.14
Muller, P.15
Jennings, G.T.16
Bachmann, M.F.17
-
37
-
-
84959735857
-
A statewide assessment of the role of Norwalk virus in outbreaks of food-borne gastroenteritis
-
Kuritsky JN, Osterholm MT, Korlath JA, White KE, Kaplan JE: A statewide assessment of the role of Norwalk virus in outbreaks of food-borne gastroenteritis. J Infect Dis 1985, 151:568.
-
(1985)
J Infect Dis
, vol.151
, pp. 568
-
-
Kuritsky, J.N.1
Osterholm, M.T.2
Korlath, J.A.3
White, K.E.4
Kaplan, J.E.5
-
38
-
-
84876931013
-
Norovirus P particle efficiently elicits innate, humoral and cellular immunity
-
This study described the data that norovirus P particle efficiently elicits innate, humoral and cellular immunity as a typical example of how a subviral particle inducing various immune responses
-
Fang H, Tan M, Xia M, Wang L, Jiang X: Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS ONE 2013, 8:e63269. This study described the data that norovirus P particle efficiently elicits innate, humoral and cellular immunity as a typical example of how a subviral particle inducing various immune responses.
-
(2013)
PLoS ONE
, vol.8
-
-
Fang, H.1
Tan, M.2
Xia, M.3
Wang, L.4
Jiang, X.5
-
39
-
-
84857030465
-
Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry
-
Bereszczak JZ, Barbu IM, Tan M, Xia M, Jiang X, van Duijn E, Heck AJ: Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry. J Struct Biol 2012, 177:273-282.
-
(2012)
J Struct Biol
, vol.177
, pp. 273-282
-
-
Bereszczak, J.Z.1
Barbu, I.M.2
Tan, M.3
Xia, M.4
Jiang, X.5
Van Duijn, E.6
Heck, A.J.7
-
40
-
-
80053400176
-
Norovirus P particle as a platform for antigen presentation
-
Tan M, Xia M, Huang P, Wang L, Zhong W, McNeal M, Wei C, Jiang X: Norovirus P particle as a platform for antigen presentation. Proc Vaccinol 2011, 4:19-26.
-
(2011)
Proc Vaccinol
, vol.4
, pp. 19-26
-
-
Tan, M.1
Xia, M.2
Huang, P.3
Wang, L.4
Zhong, W.5
McNeal, M.6
Wei, C.7
Jiang, X.8
-
41
-
-
80053580021
-
A candidate dual vaccine against influenza and noroviruses
-
Xia M, Tan M, Wei C, Zhong W, Wang L, McNeal M, Jiang X: A candidate dual vaccine against influenza and noroviruses. Vaccine 2011, 29:7670-7677.
-
(2011)
Vaccine
, vol.29
, pp. 7670-7677
-
-
Xia, M.1
Tan, M.2
Wei, C.3
Zhong, W.4
Wang, L.5
McNeal, M.6
Jiang, X.7
-
42
-
-
84893582328
-
Risk of intussusception after monovalent rotavirus vaccination
-
This new study indicated a risk of intussusception after rotavirus vaccination, suggestion a need of consideration of balancing between risks and health benefits of rotavirus vaccines
-
Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A et al.: Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med 2014. This new study indicated a risk of intussusception after rotavirus vaccination, suggestion a need of consideration of balancing between risks and health benefits of rotavirus vaccines.
-
(2014)
N Engl J Med
-
-
Weintraub, E.S.1
Baggs, J.2
Duffy, J.3
Vellozzi, C.4
Belongia, E.A.5
Irving, S.6
Klein, N.P.7
Glanz, J.M.8
Jacobsen, S.J.9
Naleway, A.10
-
43
-
-
84893551373
-
Rotavirus vaccines - Balancing intussusception risks and health benefits
-
Glass RI, Parashar UD: Rotavirus vaccines - balancing intussusception risks and health benefits. N Engl J Med 2014.
-
(2014)
N Engl J Med
-
-
Glass, R.I.1
Parashar, U.D.2
-
44
-
-
84893616243
-
Intussusception risk after rotavirus vaccination in U.S. Infants
-
Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M: Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med 2014.
-
(2014)
N Engl J Med
-
-
Yih, W.K.1
Lieu, T.A.2
Kulldorff, M.3
Martin, D.4
McMahill-Walraven, C.N.5
Platt, R.6
Selvam, N.7
Selvan, M.8
Lee, G.M.9
Nguyen, M.10
-
45
-
-
0035896012
-
Papillomavirus capsid protein expression in Escherichia coli: Purification and assembly of HPV11 and HPV16 L1
-
DOI 10.1006/jmbi.2000.4464
-
Chen XS, Casini G, Harrison SC, Garcea RL: Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J Mol Biol 2001, 307:173-182. (Pubitemid 33029974)
-
(2001)
Journal of Molecular Biology
, vol.307
, Issue.1
, pp. 173-182
-
-
Chen, X.S.1
Casini, G.2
Harrison, S.C.3
Garcea, R.L.4
-
46
-
-
84878576654
-
Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus
-
Nam HM, Chae KS, Song YJ, Lee NH, Lee JB, Park SY, Song CS, Seo KH, Kang SM, Kim MC et al.: Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus. Arch Virol 2013, 158:1275-1285.
-
(2013)
Arch Virol
, vol.158
, pp. 1275-1285
-
-
Nam, H.M.1
Chae, K.S.2
Song, Y.J.3
Lee, N.H.4
Lee, J.B.5
Park, S.Y.6
Song, C.S.7
Seo, K.H.8
Kang, S.M.9
Kim, M.C.10
-
47
-
-
0037449062
-
Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines
-
DOI 10.1016/S0264-410X(02)00804-6
-
Martinez-Torrecuadrada JL, Saubi N, Pages-Mante A, Caston JR, Espuna E, Casal JI: Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. Vaccine 2003, 21:3342-3350. (Pubitemid 36700433)
-
(2003)
Vaccine
, vol.21
, Issue.23
, pp. 3342-3350
-
-
Martinez-Torrecuadrada, J.L.1
Saubi, N.2
Pages-Mante, A.3
Caston, J.R.4
Espuna, E.5
Casal, J.I.6
-
48
-
-
0037449062
-
Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines
-
DOI 10.1016/S0264-410X(02)00822-8
-
Martinez-Torrecuadrada JL, Saubi N, Pages-Mante A, Caston JR, Espuna E, Casal JI: Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. Vaccine 2003, 21:1952-1960. (Pubitemid 36432102)
-
(2003)
Vaccine
, vol.21
, Issue.17-18
, pp. 1952-1960
-
-
Martinez-Torrecuadrada, J.L.1
Saubi, N.2
Pages-Mante, A.3
Caston, J.R.4
Espuna, E.5
Casal, J.I.6
-
49
-
-
84866042726
-
Virus-like particle-based countermeasures against Rift Valley fever virus
-
Koukuntla R, Mandell RB, Flick R: Virus-like particle-based countermeasures against Rift Valley fever virus. Zoonoses Public Health 2012, 59(Suppl 2):142-150.
-
(2012)
Zoonoses Public Health
, vol.59
, Issue.SUPPL. 2
, pp. 142-150
-
-
Koukuntla, R.1
Mandell, R.B.2
Flick, R.3
-
50
-
-
0029057747
-
Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein
-
Jiang X, Matson DO, Ruiz-Palacios GM, Hu J, Treanor J, Pickering LK: Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein. J Clin Microbiol 1995, 33:1452-1455.
-
(1995)
J Clin Microbiol
, vol.33
, pp. 1452-1455
-
-
Jiang, X.1
Matson, D.O.2
Ruiz-Palacios, G.M.3
Hu, J.4
Treanor, J.5
Pickering, L.K.6
-
51
-
-
84858280072
-
Chimeric calicivirus-like particles elicit specific immune responses in pigs
-
Crisci E, Fraile L, Moreno N, Blanco E, Cabezon R, Costa C, Mussa T, Baratelli M, Martinez-Orellana P, Ganges L et al.: Chimeric calicivirus-like particles elicit specific immune responses in pigs. Vaccine 2012, 30:2427-2439.
-
(2012)
Vaccine
, vol.30
, pp. 2427-2439
-
-
Crisci, E.1
Fraile, L.2
Moreno, N.3
Blanco, E.4
Cabezon, R.5
Costa, C.6
Mussa, T.7
Baratelli, M.8
Martinez-Orellana, P.9
Ganges, L.10
-
52
-
-
0028122560
-
Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection
-
Laurent S, Vautherot JF, Madelaine MF, Le Gall G, Rasschaert D: Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J Virol 1994, 68:6794-6798. (Pubitemid 24294936)
-
(1994)
Journal of Virology
, vol.68
, Issue.10
, pp. 6794-6798
-
-
Laurent, S.1
Vautherot, J.-F.2
Madelaine, M.-F.3
Le, G.G.4
Rasschaert, D.5
-
53
-
-
84875592440
-
Polyvalent complexes for vaccine development
-
Wang L, Huang P, Fang H, Xia M, Zhong W, McNeal MM, Jiang X, Tan M: Polyvalent complexes for vaccine development. Biomaterials 2013, 34:4480-4492.
-
(2013)
Biomaterials
, vol.34
, pp. 4480-4492
-
-
Wang, L.1
Huang, P.2
Fang, H.3
Xia, M.4
Zhong, W.5
McNeal, M.M.6
Jiang, X.7
Tan, M.8
-
54
-
-
4944266692
-
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system
-
DOI 10.1016/j.febslet.2004.09.009, PII S0014579304011238
-
Mortola E, Roy P: Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett 2004, 576:174-178. (Pubitemid 39330479)
-
(2004)
FEBS Letters
, vol.576
, Issue.1-2
, pp. 174-178
-
-
Mortola, E.1
Roy, P.2
-
55
-
-
49949116379
-
Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells
-
Bai B, Hu Q, Hu H, Zhou P, Shi Z, Meng J, Lu B, Huang Y, Mao P, Wang H: Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells. PLoS ONE 2008, 3:e2685.
-
(2008)
PLoS ONE
, vol.3
-
-
Bai, B.1
Hu, Q.2
Hu, H.3
Zhou, P.4
Shi, Z.5
Meng, J.6
Lu, B.7
Huang, Y.8
Mao, P.9
Wang, H.10
-
56
-
-
84886780209
-
Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins
-
Liu G, Lv L, Yin L, Li X, Luo D, Liu K, Xue C, Cao Y: Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins. Vaccine 2013, 31:5524-5530.
-
(2013)
Vaccine
, vol.31
, pp. 5524-5530
-
-
Liu, G.1
Lv, L.2
Yin, L.3
Li, X.4
Luo, D.5
Liu, K.6
Xue, C.7
Cao, Y.8
-
57
-
-
16244413211
-
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
-
DOI 10.1016/j.vaccine.2004.11.070
-
Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S: Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine 2005, 23:3033-3042. (Pubitemid 40462443)
-
(2005)
Vaccine
, vol.23
, Issue.23
, pp. 3033-3042
-
-
Swenson, D.L.1
Warfield, K.L.2
Negley, D.L.3
Schmaljohn, A.4
Aman, M.J.5
Bavari, S.6
-
58
-
-
0347364635
-
Ebola virus-like particles protect from lethal Ebola virus infection
-
DOI 10.1073/pnas.2237038100
-
Warfield KL, Bosio CM, Welcher BC, Deal EM, Mohamadzadeh M, Schmaljohn A, Aman MJ, Bavari S: Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci U S A 2003, 100:15889-15894. (Pubitemid 38021085)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.26
, pp. 15889-15894
-
-
Warfield, K.L.1
Bosio, C.M.2
Welcher, B.C.3
Deal, E.M.4
Mohamadzadeh, M.5
Schmaljohn, A.6
Aman, M.J.7
Bavari, S.8
-
59
-
-
0031977996
-
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells
-
Baumert TF, Ito S, Wong DT, Liang TJ: Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol 1998, 72:3827-3836. (Pubitemid 28188682)
-
(1998)
Journal of Virology
, vol.72
, Issue.5
, pp. 3827-3836
-
-
Baumert, T.F.1
Ito, S.2
Wong, D.T.3
Liang, T.J.4
-
60
-
-
2942643933
-
Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates
-
DOI 10.1128/JVI.78.13.6995-7003.2004
-
Jeong SH, Qiao M, Nascimbeni M, Hu Z, Rehermann B, Murthy K, Liang TJ: Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates. J Virol 2004, 78:6995-7003. (Pubitemid 38781538)
-
(2004)
Journal of Virology
, vol.78
, Issue.13
, pp. 6995-7003
-
-
Jeong, S.-H.1
Qiao, M.2
Nascimbeni, M.3
Hu, Z.4
Rehermann, B.5
Murthy, K.6
Liang, T.J.7
-
61
-
-
0037974714
-
Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection
-
DOI 10.1073/pnas.1131929100
-
Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ, Liang TJ: Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Acad Sci U S A 2003, 100 :6753-6758. (Pubitemid 36666652)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.11
, pp. 6753-6758
-
-
Murata, K.1
Lechmann, M.2
Qiao, M.3
Gunji, T.4
Altert, H.J.5
Liang, T.J.6
-
62
-
-
84878804020
-
Prospects for prophylactic hepatitis C vaccines based on virus-like particles
-
Beaumont E, Roingeard P: Prospects for prophylactic hepatitis C vaccines based on virus-like particles. Hum Vaccin Immunother 2013, 9:1112-1118.
-
(2013)
Hum Vaccin Immunother
, vol.9
, pp. 1112-1118
-
-
Beaumont, E.1
Roingeard, P.2
-
63
-
-
21144480904
-
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial
-
DOI 10.1128/IAI.73.6.3587-3597.2005
-
Oliveira GA, Wetzel K, Calvo-Calle JM, Nussenzweig R, Schmidt A, Birkett A, Dubovsky F, Tierney E, Gleiter CH, Boehmer G et al.: Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial. Infect Immun 2005, 73:3587-3597. (Pubitemid 40745903)
-
(2005)
Infection and Immunity
, vol.73
, Issue.6
, pp. 3587-3597
-
-
Oliveira, G.A.1
Wetzel, K.2
Calvo-Calle, J.M.3
Nussenzweig, R.4
Schmidt, A.5
Birkett, A.6
Dubovsky, F.7
Tierney, E.8
Gleiter, C.H.9
Boehmer, G.10
Luty, A.J.F.11
Ramharter, M.12
Thornton, G.B.13
Kremsner, P.G.14
Nardin, E.H.15
-
64
-
-
14744292190
-
A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula
-
DOI 10.1002/eji.200425449
-
Nassal M, Skamel C, Kratz PA, Wallich R, Stehle T, Simon MM: A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Eur J Immunol 2005, 35:655-665. (Pubitemid 40331342)
-
(2005)
European Journal of Immunology
, vol.35
, Issue.2
, pp. 655-665
-
-
Nassal, M.1
Skamel, C.2
Kratz, P.A.3
Wallich, R.4
Stehle, T.5
Simon, M.M.6
-
65
-
-
84896908376
-
Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: New particulate Lyme disease vaccines
-
Nassal M, Skamel C, Vogel M, Kratz PA, Stehle T, Wallich R, Simon MM: Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines. Int J Med Microbiol 2007.
-
(2007)
Int J Med Microbiol
-
-
Nassal, M.1
Skamel, C.2
Vogel, M.3
Kratz, P.A.4
Stehle, T.5
Wallich, R.6
Simon, M.M.7
-
66
-
-
26444507185
-
Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus
-
DOI 10.1128/JVI.79.20.12999-13006.2005
-
Li TC, Takeda N, Miyamura T, Matsuura Y, Wang JC, Engvall H, Hammar L, Xing L, Cheng RH: Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol 2005, 79:12999-13006. (Pubitemid 41433219)
-
(2005)
Journal of Virology
, vol.79
, Issue.20
, pp. 12999-13006
-
-
Li, T.-C.1
Takeda, N.2
Miyamura, T.3
Matsuura, Y.4
Wang, J.C.Y.5
Engvall, H.6
Hammar, L.7
Xing, L.8
Cheng, R.H.9
-
67
-
-
0038330622
-
Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine
-
DOI 10.1016/S0264-410X(03)00100-2
-
Purcell RH, Nguyen H, Shapiro M, Engle RE, Govindarajan S, Blackwelder WC, Wong DC, Prieels JP, Emerson SU: Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003, 21:2607-2615. (Pubitemid 36564834)
-
(2003)
Vaccine
, vol.21
, Issue.19-20
, pp. 2607-2615
-
-
Purcell, R.H.1
Nguyen, H.2
Shapiro, M.3
Engle, R.E.4
Govindarajan, S.5
Blackwelder, W.C.6
Wong, D.C.7
Prieels, J.-P.8
Emerson, S.U.9
-
68
-
-
77956618583
-
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A largescale, randomised, double-blind placebo-controlled, phase 3 trial
-
Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP et al.: Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a largescale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010, 376:895-902.
-
(2010)
Lancet
, vol.376
, pp. 895-902
-
-
Zhu, F.C.1
Zhang, J.2
Zhang, X.F.3
Zhou, C.4
Wang, Z.Z.5
Huang, S.J.6
Wang, H.7
Yang, C.L.8
Jiang, H.M.9
Cai, J.P.10
-
69
-
-
84855827464
-
A virus-like particle-based Epstein-Barr virus vaccine
-
Ruiss R, Jochum S, Wanner G, Reisbach G, Hammerschmidt W, Zeidler R: A virus-like particle-based Epstein-Barr virus vaccine. J Virol 2011, 85:13105-13113.
-
(2011)
J Virol
, vol.85
, pp. 13105-13113
-
-
Ruiss, R.1
Jochum, S.2
Wanner, G.3
Reisbach, G.4
Hammerschmidt, W.5
Zeidler, R.6
-
70
-
-
33749455623
-
Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles
-
DOI 10.1128/JVI.01098-06
-
Thiery R, Cozien J, Cabon J, Lamour F, Baud M, Schneemann A: Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles. J Virol 2006, 80:10201-10207. (Pubitemid 44522613)
-
(2006)
Journal of Virology
, vol.80
, Issue.20
, pp. 10201-10207
-
-
Thiery, R.1
Cozien, J.2
Cabon, J.3
Lamour, F.4
Baud, M.5
Schneemann, A.6
-
71
-
-
0036115177
-
Virus-like particles of a fish nodavirus display a capsid subunit domain organization different from that of insect nodaviruses
-
DOI 10.1128/JVI.76.12.6370-6375.2002
-
Tang L, Lin CS, Krishna NK, Yeager M, Schneemann A, Johnson JE: Virus-like particles of a fish nodavirus display a capsid subunit domain organization different from that of insect nodaviruses. J Virol 2002, 76:6370-6375. (Pubitemid 34556332)
-
(2002)
Journal of Virology
, vol.76
, Issue.12
, pp. 6370-6375
-
-
Tang, L.1
Lin, C.-S.2
Krishna, N.K.3
Yeager, M.4
Schneemann, A.5
Johnson, J.E.6
-
72
-
-
36048968101
-
A viral nanoparticle with dual function as an anthrax antitoxin and vaccine
-
Manayani DJ, Thomas D, Dryden KA, Reddy V, Siladi ME, Marlett JM, Rainey GJ, Pique ME, Scobie HM, Yeager M et al.: A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. PLoS Pathog 2007, 3 :e142.
-
(2007)
PLoS Pathog
, vol.3
-
-
Manayani, D.J.1
Thomas, D.2
Dryden, K.A.3
Reddy, V.4
Siladi, M.E.5
Marlett, J.M.6
Rainey, G.J.7
Pique, M.E.8
Scobie, H.M.9
Yeager, M.10
-
73
-
-
77950656840
-
Influenza virus-like particles as pandemic vaccines
-
Kang SM, Pushko P, Bright RA, Smith G, Compans RW: Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol 2009, 333:269-289.
-
(2009)
Curr Top Microbiol Immunol
, vol.333
, pp. 269-289
-
-
Kang, S.M.1
Pushko, P.2
Bright, R.A.3
Smith, G.4
Compans, R.W.5
-
74
-
-
66149101000
-
Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge
-
Perrone LA, Ahmad A, Veguilla V, Lu X, Smith G, Katz JM, Pushko P, Tumpey TM: Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 2009, 83:5726-5734.
-
(2009)
J Virol
, vol.83
, pp. 5726-5734
-
-
Perrone, L.A.1
Ahmad, A.2
Veguilla, V.3
Lu, X.4
Smith, G.5
Katz, J.M.6
Pushko, P.7
Tumpey, T.M.8
-
75
-
-
79960728140
-
Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes
-
Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, Tumpey TM: Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes. Vaccine 2011, 29:5911-5918.
-
(2011)
Vaccine
, vol.29
, pp. 5911-5918
-
-
Pushko, P.1
Pearce, M.B.2
Ahmad, A.3
Tretyakova, I.4
Smith, G.5
Belser, J.A.6
Tumpey, T.M.7
-
76
-
-
84897015358
-
Virus-like particle vaccine confers protection against a lethal NDV challenge in chickens and allows DIVA strategy
-
Park JK, Lee DH, Yuk SS, To EO, Kwon JH, Noh JY, Kim BY, Choi SW, Kang SM, Lee JB et al.: Virus-like particle vaccine confers protection against a lethal NDV challenge in chickens and allows DIVA strategy. Clin Vaccine Immunol 2014.
-
(2014)
Clin Vaccine Immunol
-
-
Park, J.K.1
Lee, D.H.2
Yuk, S.S.3
To, E.O.4
Kwon, J.H.5
Noh, J.Y.6
Kim, B.Y.7
Choi, S.W.8
Kang, S.M.9
Lee, J.B.10
-
77
-
-
80052406550
-
Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice
-
Quan FS, Kim Y, Lee S, Yi H, Kang SM, Bozja J, Moore ML, Compans RW: Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. J Infect Dis 2011, 204 :987-995.
-
(2011)
J Infect Dis
, vol.204
, pp. 987-995
-
-
Quan, F.S.1
Kim, Y.2
Lee, S.3
Yi, H.4
Kang, S.M.5
Bozja, J.6
Moore, M.L.7
Compans, R.W.8
-
78
-
-
33744826259
-
A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure
-
DOI 10.1016/j.vaccine.2006.03.089, PII S0264410X06004178
-
Antonis AF, Bruschke CJ, Rueda P, Maranga L, Casal JI, Vela C, Hilgers LA, Belt PB, Weerdmeester K, Carrondo MJ et al. : A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure. Vaccine 2006, 24:5481-5490. (Pubitemid 43831379)
-
(2006)
Vaccine
, vol.24
, Issue.26
, pp. 5481-5490
-
-
Antonis, A.F.G.1
Bruschke, C.J.M.2
Rueda, P.3
Maranga, L.4
Casal, J.I.5
Vela, C.6
Hilgers, L.A.Th.7
Belt, P.B.G.M.8
Weerdmeester, K.9
Carrondo, M.J.T.10
Langeveld, J.P.M.11
-
79
-
-
0026531008
-
Canine parvovirus empty capsids produced by expression in a baculovirus vector: Use in analysis of viral properties and immunization of dogs
-
Saliki JT, Mizak B, Flore HP, Gettig RR, Burand JP, Carmichael LE, Wood HA, Parrish CR: Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J Gen Virol 1992, 73(Pt 2):369-374.
-
(1992)
J Gen Virol
, vol.73
, Issue.PART 2
, pp. 369-374
-
-
Saliki, J.T.1
Mizak, B.2
Flore, H.P.3
Gettig, R.R.4
Burand, J.P.5
Carmichael, L.E.6
Wood, H.A.7
Parrish, C.R.8
-
80
-
-
0026528538
-
Recombinant vaccine for canine parvovirus in dogs
-
Lopez de Turiso JA, Cortes E, Martinez C, Ruiz de Ybanez R, Simarro I, Vela C, Casal I: Recombinant vaccine for canine parvovirus in dogs. J Virol 1992, 66:2748-2753.
-
(1992)
J Virol
, vol.66
, pp. 2748-2753
-
-
Lopez De Turiso, J.A.1
Cortes, E.2
Martinez, C.3
Ruiz De Ybanez, R.4
Simarro, I.5
Vela, C.6
Casal, I.7
-
81
-
-
84898897838
-
Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine
-
Xu J, Guo HC, Wei YQ, Dong H, Han SC, Ao D, Sun DH, Wang HM, Cao SZ, Sun SQ: Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine. Appl Microbiol Biotechnol 2014.
-
(2014)
Appl Microbiol Biotechnol
-
-
Xu, J.1
Guo, H.C.2
Wei, Y.Q.3
Dong, H.4
Han, S.C.5
Ao, D.6
Sun, D.H.7
Wang, H.M.8
Cao, S.Z.9
Sun, S.Q.10
-
82
-
-
79956200555
-
Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose
-
Ju H, Wei N, Wang Q, Wang C, Jing Z, Guo L, Liu D, Gao M, Ma B, Wang J: Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose. Biochem Biophys Res Commun 2011, 409:131-136.
-
(2011)
Biochem Biophys Res Commun
, vol.409
, pp. 131-136
-
-
Ju, H.1
Wei, N.2
Wang, Q.3
Wang, C.4
Jing, Z.5
Guo, L.6
Liu, D.7
Gao, M.8
Ma, B.9
Wang, J.10
-
83
-
-
84881557289
-
Generation of a parvovirus B19 vaccine candidate
-
Chandramouli S, Medina-Selby A, Coit D, Schaefer M, Spencer T, Brito LA, Zhang P, Otten G, Mandl CW, Mason PW et al.: Generation of a parvovirus B19 vaccine candidate. Vaccine 2013, 31:3872-3878.
-
(2013)
Vaccine
, vol.31
, pp. 3872-3878
-
-
Chandramouli, S.1
Medina-Selby, A.2
Coit, D.3
Schaefer, M.4
Spencer, T.5
Brito, L.A.6
Zhang, P.7
Otten, G.8
Mandl, C.W.9
Mason, P.W.10
-
84
-
-
80053436637
-
Safety and immunogenicity of a candidate parvovirus B19 vaccine
-
Bernstein DI, El Sahly HM, Keitel WA, Wolff M, Simone G, Segawa C, Wong S, Shelly D, Young NS, Dempsey W: Safety and immunogenicity of a candidate parvovirus B19 vaccine. Vaccine 2011, 29:7357-7363.
-
(2011)
Vaccine
, vol.29
, pp. 7357-7363
-
-
Bernstein, D.I.1
El Sahly, H.M.2
Keitel, W.A.3
Wolff, M.4
Simone, G.5
Segawa, C.6
Wong, S.7
Shelly, D.8
Young, N.S.9
Dempsey, W.10
-
85
-
-
0031780717
-
Human papillomavirus type 11 recombinant L1 capsomeres induce virus- neutralizing antibodies
-
Rose RC, White WI, Li M, Suzich JA, Lane C, Garcea RL: Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies. J Virol 1998, 72:6151-6154. (Pubitemid 28283406)
-
(1998)
Journal of Virology
, vol.72
, Issue.7
, pp. 6151-6154
-
-
Rose, R.C.1
White, W.I.2
Li, M.3
Suzich, J.A.4
Lane, C.5
Garcea, R.L.6
-
86
-
-
0034872411
-
Immunization with a pentameric L1 fusion protein protects against papillomavirus infection
-
DOI 10.1128/JVI.75.17.7848-7853.2001
-
Yuan H, Estes PA, Chen Y, Newsome J, Olcese VA, Garcea RL, Schlegel R: Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J Virol 2001, 75:7848-7853. (Pubitemid 32743655)
-
(2001)
Journal of Virology
, vol.75
, Issue.17
, pp. 7848-7853
-
-
Yuan, H.1
Eestes, P.A.2
Chen, Y.3
Newsome, J.4
Olcese, V.A.5
Garcea, R.L.6
Schlegel, R.7
-
87
-
-
79955121411
-
Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
-
Jeoung HY, Lee WH, Jeong W, Shin BH, Choi HW, Lee HS, An DJ: Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig. Virol J 2011, 8:170.
-
(2011)
Virol J
, vol.8
, pp. 170
-
-
Jeoung, H.Y.1
Lee, W.H.2
Jeong, W.3
Shin, B.H.4
Choi, H.W.5
Lee, H.S.6
An, D.J.7
-
88
-
-
84862809216
-
Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis
-
Zhang L, Parham NJ, Zhang F, Aasa-Chapman M, Gould EA, Zhang H: Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis. Vaccine 2012, 30:2301-2308.
-
(2012)
Vaccine
, vol.30
, pp. 2301-2308
-
-
Zhang, L.1
Parham, N.J.2
Zhang, F.3
Aasa-Chapman, M.4
Gould, E.A.5
Zhang, H.6
-
89
-
-
84867482187
-
A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge
-
Liu Q, Yan K, Feng Y, Huang X, Ku Z, Cai Y, Liu F, Shi J, Huang Z: A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 2012, 30:6642-6648.
-
(2012)
Vaccine
, vol.30
, pp. 6642-6648
-
-
Liu, Q.1
Yan, K.2
Feng, Y.3
Huang, X.4
Ku, Z.5
Cai, Y.6
Liu, F.7
Shi, J.8
Huang, Z.9
-
90
-
-
40849137446
-
Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge
-
Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC: Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
-
(2008)
Vaccine
, vol.26
, pp. 1855-1862
-
-
Chung, Y.C.1
Ho, M.S.2
Wu, J.C.3
Chen, W.J.4
Huang, J.H.5
Chou, S.T.6
Hu, Y.C.7
-
91
-
-
84862786637
-
Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles
-
Lin YL, Yu CI, Hu YC, Tsai TJ, Kuo YC, Chi WK, Lin AN, Chiang BL: Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine 2012, 30:1305-1312.
-
(2012)
Vaccine
, vol.30
, pp. 1305-1312
-
-
Lin, Y.L.1
Yu, C.I.2
Hu, Y.C.3
Tsai, T.J.4
Kuo, Y.C.5
Chi, W.K.6
Lin, A.N.7
Chiang, B.L.8
-
92
-
-
84879460493
-
Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice
-
Li HY, Han JF, Qin CF, Chen R: Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine 2013, 31:3281-3287.
-
(2013)
Vaccine
, vol.31
, pp. 3281-3287
-
-
Li, H.Y.1
Han, J.F.2
Qin, C.F.3
Chen, R.4
-
93
-
-
84888008597
-
Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge
-
Bhat SA, Saravanan P, Hosamani M, Basagoudanavar SH, Sreenivasa BP, Tamilselvan RP, Venkataramanan R: Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge. Res Vet Sci 2013, 95:1217-1223.
-
(2013)
Res Vet Sci
, vol.95
, pp. 1217-1223
-
-
Bhat, S.A.1
Saravanan, P.2
Hosamani, M.3
Basagoudanavar, S.H.4
Sreenivasa, B.P.5
Tamilselvan, R.P.6
Venkataramanan, R.7
-
94
-
-
84879815475
-
Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle
-
Guo HC, Sun SQ, Jin Y, Yang SL, Wei YQ, Sun DH, Yin SH, Ma JW, Liu ZX, Guo JH et al.: Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res 2013, 44 :48.
-
(2013)
Vet Res
, vol.44
, pp. 48
-
-
Guo, H.C.1
Sun, S.Q.2
Jin, Y.3
Yang, S.L.4
Wei, Y.Q.5
Sun, D.H.6
Yin, S.H.7
Ma, J.W.8
Liu, Z.X.9
Guo, J.H.10
-
95
-
-
0342323856
-
Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein
-
DOI 10.1006/viro.2000.0392
-
Gedvilaite A, Frommel C, Sasnauskas K, Micheel B, Ozel M, Behrsing O, Staniulis J, Jandrig B, Scherneck S, Ulrich R: Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Virology 2000, 273:21-35. (Pubitemid 30602004)
-
(2000)
Virology
, vol.273
, Issue.1
, pp. 21-35
-
-
Gedvilaite, A.1
Frommel, C.2
Sasnauskas, K.3
Micheel, B.4
Ozel, M.5
Behrsing, O.6
Staniulis, J.7
Jandrig, B.8
Scherneck, S.9
Ulrich, R.10
-
96
-
-
1542513302
-
Segments of Puumala Hantavirus Nucleocapsid Protein Inserted into Chimeric Polyomavirus-Derived Virus-Like Particles Induce a Strong Immune Response in Mice
-
DOI 10.1089/088282404322875458
-
Gedvilaite A, Zvirbliene A, Staniulis J, Sasnauskas K, Kruger DH, Ulrich R: Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice. Viral Immunol 2004, 17:51-68. (Pubitemid 38338462)
-
(2004)
Viral Immunology
, vol.17
, Issue.1
, pp. 51-68
-
-
Gedvilaite, A.1
Zvirbliene, A.2
Staniulis, J.3
Sasnauskas, K.4
Kruger, D.H.5
Ulrich, R.6
-
97
-
-
41349109392
-
Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope
-
Dorn DC, Lawatscheck R, Zvirbliene A, Aleksaite E, Pecher G, Sasnauskas K, Ozel M, Raftery M, Schonrich G, Ulrich RG et al.: Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope. Viral Immunol 2008, 21:12-27.
-
(2008)
Viral Immunol
, vol.21
, pp. 12-27
-
-
Dorn, D.C.1
Lawatscheck, R.2
Zvirbliene, A.3
Aleksaite, E.4
Pecher, G.5
Sasnauskas, K.6
Ozel, M.7
Raftery, M.8
Schonrich, G.9
Ulrich, R.G.10
-
98
-
-
84855584421
-
Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope
-
Mazeike E, Gedvilaite A, Blohm U: Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope. Virus Res 2012, 163:2-10.
-
(2012)
Virus Res
, vol.163
, pp. 2-10
-
-
Mazeike, E.1
Gedvilaite, A.2
Blohm, U.3
-
99
-
-
84875244225
-
Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS)
-
Rivera-Hernandez T, Hartas J, Wu Y, Chuan YP, Lua LH, Good M, Batzloff MR, Middelberg AP: Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS). Vaccine 2013, 31:1950-1955.
-
(2013)
Vaccine
, vol.31
, pp. 1950-1955
-
-
Rivera-Hernandez, T.1
Hartas, J.2
Wu, Y.3
Chuan, Y.P.4
Lua, L.H.5
Good, M.6
Batzloff, M.R.7
Middelberg, A.P.8
-
100
-
-
21344434789
-
A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors
-
DOI 10.1158/0008-5472.CAN-05-0335
-
Tegerstedt K, Lindencrona JA, Curcio C, Andreasson K, Tullus C, Forni G, Dalianis T, Kiessling R, Ramqvist T: A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors. Cancer Res 2005, 65:5953-5957. (Pubitemid 40911202)
-
(2005)
Cancer Research
, vol.65
, Issue.13
, pp. 5953-5957
-
-
Tegerstedt, K.1
Lindencrona, J.A.2
Curcio, C.3
Andreasson, K.4
Tullus, C.5
Forni, G.6
Dalianis, T.7
Kiessling, R.8
Ramqvist, T.9
-
101
-
-
80051766150
-
Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor
-
Eriksson M, Andreasson K, Weidmann J, Lundberg K, Tegerstedt K, Dalianis T, Ramqvist T: Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor. PLoS ONE 2011, 6:e23828.
-
(2011)
PLoS ONE
, vol.6
-
-
Eriksson, M.1
Andreasson, K.2
Weidmann, J.3
Lundberg, K.4
Tegerstedt, K.5
Dalianis, T.6
Ramqvist, T.7
-
102
-
-
39049183787
-
Development of a vaccine marker technology: Display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination
-
Neugebauer M, Walders B, Brinkman M, Ruehland C, Schumacher T, Bertling WM, Geuther E, Reiser CO, Reichel C, Strich S et al.: Development of a vaccine marker technology: display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination. Biotechnol J 2006, 1:1435-1446.
-
(2006)
Biotechnol J
, vol.1
, pp. 1435-1446
-
-
Neugebauer, M.1
Walders, B.2
Brinkman, M.3
Ruehland, C.4
Schumacher, T.5
Bertling, W.M.6
Geuther, E.7
Reiser, C.O.8
Reichel, C.9
Strich, S.10
-
103
-
-
84874082507
-
SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier
-
Kawano M, Matsui M, Handa H: SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier. Expert Rev Vaccines 2013, 12:199-210.
-
(2013)
Expert Rev Vaccines
, vol.12
, pp. 199-210
-
-
Kawano, M.1
Matsui, M.2
Handa, H.3
-
104
-
-
79952804470
-
Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery
-
Zhao Q, Chen W, Chen Y, Zhang L, Zhang J, Zhang Z: Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjug Chem 2011, 22:346-352.
-
(2011)
Bioconjug Chem
, vol.22
, pp. 346-352
-
-
Zhao, Q.1
Chen, W.2
Chen, Y.3
Zhang, L.4
Zhang, J.5
Zhang, Z.6
-
105
-
-
77955676002
-
VP6: A candidate rotavirus vaccine
-
Ward RL, McNeal MM: VP6: a candidate rotavirus vaccine. J Infect Dis 2010, 202(Suppl):S101-S107.
-
(2010)
J Infect Dis
, vol.202
, Issue.SUPPL.
-
-
Ward, R.L.1
McNeal, M.M.2
-
106
-
-
84874054717
-
Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease
-
Azevedo MP, Vlasova AN, Saif LJ: Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease. Expert Rev Vaccines 2013, 12:169-181.
-
(2013)
Expert Rev Vaccines
, vol.12
, pp. 169-181
-
-
Azevedo, M.P.1
Vlasova, A.N.2
Saif, L.J.3
-
107
-
-
0026601133
-
Protective efficacy of virus-like particles for bluetongue disease
-
Roy P, French T, Erasmus BJ: Protective efficacy of virus-like particles for bluetongue disease. Vaccine 1992, 10:28-32.
-
(1992)
Vaccine
, vol.10
, pp. 28-32
-
-
Roy, P.1
French, T.2
Erasmus, B.J.3
-
108
-
-
0025331991
-
Recombinant virus vaccine for bluetongue disease in sheep
-
Roy P, Urakawa T, Van Dijk AA, Erasmus BJ: Recombinant virus vaccine for bluetongue disease in sheep. J Virol 1990, 64:1998-2003. (Pubitemid 20148441)
-
(1990)
Journal of Virology
, vol.64
, Issue.5
, pp. 1998-2003
-
-
Roy, P.1
Urakawa, T.2
Van Dijk, A.A.3
Erasmus, B.J.4
-
109
-
-
84871664118
-
Bluetongue virus serotype 8 viruslike particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen
-
Stewart M, Dubois E, Sailleau C, Breard E, Viarouge C, Desprat A, Thiery R, Zientara S, Roy P: Bluetongue virus serotype 8 viruslike particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen. Vaccine 2013, 31:553-558.
-
(2013)
Vaccine
, vol.31
, pp. 553-558
-
-
Stewart, M.1
Dubois, E.2
Sailleau, C.3
Breard, E.4
Viarouge, C.5
Desprat, A.6
Thiery, R.7
Zientara, S.8
Roy, P.9
-
110
-
-
14844300825
-
Virus-like particles as HIV-1 vaccines
-
DOI 10.1002/rmv.449
-
Doan LX, Li M, Chen C, Yao Q: Virus-like particles as HIV-1 vaccines. Rev Med Virol 2005, 15:75-88. (Pubitemid 40343192)
-
(2005)
Reviews in Medical Virology
, vol.15
, Issue.2
, pp. 75-88
-
-
Doan, L.X.1
Li, M.2
Chen, C.3
Yao, Q.4
-
111
-
-
77949264955
-
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
-
Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA, Kong WP, Lewis MG, Higgs S, Rossmann MG, Rao S et al.: A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med 2010, 16:334-338.
-
(2010)
Nat Med
, vol.16
, pp. 334-338
-
-
Akahata, W.1
Yang, Z.Y.2
Andersen, H.3
Sun, S.4
Holdaway, H.A.5
Kong, W.P.6
Lewis, M.G.7
Higgs, S.8
Rossmann, M.G.9
Rao, S.10
-
112
-
-
0029057169
-
Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine
-
Gordon DM, McGovern TW, Krzych U, Cohen JC, Schneider I, LaChance R, Heppner DG, Yuan G, Hollingdale M, Slaoui M et al.: Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis 1995, 171:1576-1585.
-
(1995)
J Infect Dis
, vol.171
, pp. 1576-1585
-
-
Gordon, D.M.1
McGovern, T.W.2
Krzych, U.3
Cohen, J.C.4
Schneider, I.5
LaChance, R.6
Heppner, D.G.7
Yuan, G.8
Hollingdale, M.9
Slaoui, M.10
-
113
-
-
34250801476
-
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults
-
DOI 10.1016/j.vaccine.2007.05.005, PII S0264410X07005609
-
Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG Jr, Hall T, Wellde BT, White K, Sun P, Schwenk R et al.: A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults. Vaccine 2007, 25:5359-5366. (Pubitemid 46977534)
-
(2007)
Vaccine
, vol.25
, Issue.29
, pp. 5359-5366
-
-
Kester, K.E.1
McKinney, D.A.2
Tornieporth, N.3
Ockenhouse, C.F.4
Heppner Jr., D.G.5
Hall, T.6
Wellde, B.T.7
White, K.8
Sun, P.9
Schwenk, R.10
Krzych, U.11
Delchambre, M.12
Voss, G.13
Dubois, M.-C.14
Gasser Jr., R.A.15
Dowler, M.G.16
O'Brien, M.17
Wittes, J.18
Wirtz, R.19
Cohen, J.20
Ballou, W.R.21
more..
-
114
-
-
33646949257
-
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
-
DOI 10.1016/j.jaci.2006.01.040, PII S0091674906002983
-
Kundig TM, Senti G, Schnetzler G, Wolf C, Prinz Vavricka BM, Fulurija A, Hennecke F, Sladko K, Jennings GT, Bachmann MF: Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol 2006, 117:1470-1476. (Pubitemid 43795737)
-
(2006)
Journal of Allergy and Clinical Immunology
, vol.117
, Issue.6
, pp. 1470-1476
-
-
Kundig, T.M.1
Senti, G.2
Schnetzler, G.3
Wolf, C.4
Prinz, V.B.M.5
Fulurija, A.6
Hennecke, F.7
Sladko, K.8
Jennings, G.T.9
Bachmann, M.F.10
-
115
-
-
0030891738
-
Plant-derived vaccine protects target animals against a viral disease
-
Dalsgaard K, Uttenthal A, Jones TD, Xu F, Merryweather A, Hamilton WD, Langeveld JP, Boshuizen RS, Kamstrup S, Lomonossoff GP et al.: Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol 1997, 15:248-252. (Pubitemid 27118269)
-
(1997)
Nature Biotechnology
, vol.15
, Issue.3
, pp. 248-252
-
-
Dalsgaard, K.1
Uttentha, A.2
Jones, T.D.3
Xu, F.4
Merryweather, A.5
Hamilton, W.D.O.6
Langeveld, J.P.M.7
Boshuizen, R.S.8
Kamstrup, S.9
Lomonossoff, G.P.10
Porta, C.11
Vela, C.12
Ignacio, C.J.13
Meloen, R.H.14
Rodgers, P.B.15
-
116
-
-
0032921502
-
Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus
-
Brennan FR, Jones TD, Gilleland LB, Bellaby T, Xu F, North PC, Thompson A, Staczek J, Lin T, Johnson JE et al.: Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiology 1999, 145(Pt 1):211-220. (Pubitemid 29043593)
-
(1999)
Microbiology
, vol.145
, Issue.1
, pp. 211-220
-
-
Brennan, F.R.1
Jones, T.D.2
Gilleland, L.B.3
Bellaby, T.4
Xu, F.5
North, P.C.6
Thompson, A.7
Staczek, J.8
Lin, T.9
Johnson, J.E.10
Hamilton, W.D.O.11
Gilleland Jr., H.E.12
-
117
-
-
0035858128
-
Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat
-
DOI 10.1016/S0264-410X(01)00080-9, PII S0264410X01000809
-
Rennermalm A, Li YH, Bohaufs L, Jarstrand C, Brauner A, Brennan FR, Flock JI: Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine 2001, 19:3376-3383. (Pubitemid 32710286)
-
(2001)
Vaccine
, vol.19
, Issue.25-26
, pp. 3376-3383
-
-
Rennermalm, A.1
Li, Y.-H.2
Bohaufs, L.3
Jarstrand, C.4
Brauner, A.5
Brennan, F.R.6
Flock, J.-I.7
-
118
-
-
84896989856
-
Production and immunogenicity of chimeric virus-like particles (VLPs) containing the spike (S1) glycoprotein of infectious bronchitis virus (IBV)
-
Lv L, Li X, Liu G, Li R, Liu Q, Shen H, Wang W, Xue C, Cao Y: Production and immunogenicity of chimeric virus-like particles (VLPs) containing the spike (S1) glycoprotein of infectious bronchitis virus (IBV). J Vet Sci 2013.
-
(2013)
J Vet Sci
-
-
Lv, L.1
Li, X.2
Liu, G.3
Li, R.4
Liu, Q.5
Shen, H.6
Wang, W.7
Xue, C.8
Cao, Y.9
-
119
-
-
84888206375
-
Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease
-
Shen H, Xue C, Lv L, Wang W, Liu Q, Liu K, Chen X, Zheng J, Li X, Cao Y: Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease. Virus Res 2013, 178:430-436.
-
(2013)
Virus Res
, vol.178
, pp. 430-436
-
-
Shen, H.1
Xue, C.2
Lv, L.3
Wang, W.4
Liu, Q.5
Liu, K.6
Chen, X.7
Zheng, J.8
Li, X.9
Cao, Y.10
-
120
-
-
84880686616
-
Construction, expression and immunogenicity of a novel antihypertension angiotensin II vaccine based on hepatitis A virus-like particle
-
Ou X, Guo L, Wu J, Mi K, Yin N, Zhang G, Li H, Sun M: Construction, expression and immunogenicity of a novel antihypertension angiotensin II vaccine based on hepatitis A virus-like particle. Hum Vaccin Immunother 2013, 9:1191-1199.
-
(2013)
Hum Vaccin Immunother
, vol.9
, pp. 1191-1199
-
-
Ou, X.1
Guo, L.2
Wu, J.3
Mi, K.4
Yin, N.5
Zhang, G.6
Li, H.7
Sun, M.8
-
121
-
-
84890876293
-
Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms
-
Ye X, Ku Z, Liu Q, Wang X, Shi J, Zhang Y, Kong L, Cong Y, Huang Z: Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms. J Virol 2014, 88:72-81.
-
(2014)
J Virol
, vol.88
, pp. 72-81
-
-
Ye, X.1
Ku, Z.2
Liu, Q.3
Wang, X.4
Shi, J.5
Zhang, Y.6
Kong, L.7
Cong, Y.8
Huang, Z.9
-
122
-
-
77953148122
-
Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes
-
Sominskaya I, Skrastina D, Dislers A, Vasiljev D, Mihailova M, Ose V, Dreilina D, Pumpens P: Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes. Clin Vaccine Immunol 2010, 17:1027-1033.
-
(2010)
Clin Vaccine Immunol
, vol.17
, pp. 1027-1033
-
-
Sominskaya, I.1
Skrastina, D.2
Dislers, A.3
Vasiljev, D.4
Mihailova, M.5
Ose, V.6
Dreilina, D.7
Pumpens, P.8
-
123
-
-
34447276481
-
Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies
-
Vietheer PT, Boo I, Drummer HE, Netter HJ: Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. Antivir Ther 2007, 12:477-487. (Pubitemid 47041146)
-
(2007)
Antiviral Therapy
, vol.12
, Issue.4
, pp. 477-487
-
-
Vietheer, P.T.K.1
Boo, I.2
Drummer, H.E.3
Netter, H.-J.4
-
124
-
-
84864607163
-
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
-
Arora U, Tyagi P, Swaminathan S, Khanna N: Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2. J Nanobiotechnol 2012, 10:30.
-
(2012)
J Nanobiotechnol
, vol.10
, pp. 30
-
-
Arora, U.1
Tyagi, P.2
Swaminathan, S.3
Khanna, N.4
-
125
-
-
84872610842
-
Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice
-
Arora U, Tyagi P, Swaminathan S, Khanna N: Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice. Vaccine 2013, 31:873-878.
-
(2013)
Vaccine
, vol.31
, pp. 873-878
-
-
Arora, U.1
Tyagi, P.2
Swaminathan, S.3
Khanna, N.4
-
126
-
-
84886732776
-
Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein
-
Skrastina D, Petrovskis I, Petraityte R, Sominskaya I, Ose V, Lieknina I, Bogans J, Sasnauskas K, Pumpens P: Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein. Clin Vaccine Immunol 2013, 20:1719-1728.
-
(2013)
Clin Vaccine Immunol
, vol.20
, pp. 1719-1728
-
-
Skrastina, D.1
Petrovskis, I.2
Petraityte, R.3
Sominskaya, I.4
Ose, V.5
Lieknina, I.6
Bogans, J.7
Sasnauskas, K.8
Pumpens, P.9
-
127
-
-
84862813537
-
Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV
-
Wang YS, Ouyang W, Liu XJ, He KW, Yu SQ, Zhang HB, Fan HJ, Lu CP: Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV. Vaccine 2012, 30:2125-2130.
-
(2012)
Vaccine
, vol.30
, pp. 2125-2130
-
-
Wang, Y.S.1
Ouyang, W.2
Liu, X.J.3
He, K.W.4
Yu, S.Q.5
Zhang, H.B.6
Fan, H.J.7
Lu, C.P.8
-
128
-
-
84874822639
-
Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles
-
Dhanasooraj D, Kumar RA, Mundayoor S: Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles. Int J Nanomed 2013, 8:835-843.
-
(2013)
Int J Nanomed
, vol.8
, pp. 835-843
-
-
Dhanasooraj, D.1
Kumar, R.A.2
Mundayoor, S.3
-
129
-
-
84876671666
-
A novel platform for virus-like particle-display of flaviviral envelope domain III: Induction of Dengue and West Nile virus neutralizing antibodies
-
Chua AJ, Vituret C, Tan ML, Gonzalez G, Boulanger P, Ng ML, Hong SS: A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies. Virol J 2013, 10:129.
-
(2013)
Virol J
, vol.10
, pp. 129
-
-
Chua, A.J.1
Vituret, C.2
Tan, M.L.3
Gonzalez, G.4
Boulanger, P.5
Ng, M.L.6
Hong, S.S.7
-
130
-
-
84878351256
-
Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice
-
Levy C, Aerts L, Hamelin ME, Granier C, Szecsi J, Lavillette D, Boivin G, Cosset FL: Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice. Vaccine 2013, 31:2778-2785.
-
(2013)
Vaccine
, vol.31
, pp. 2778-2785
-
-
Levy, C.1
Aerts, L.2
Hamelin, M.E.3
Granier, C.4
Szecsi, J.5
Lavillette, D.6
Boivin, G.7
Cosset, F.L.8
-
131
-
-
84896997060
-
A dual vaccine candidate against norovirus and hepatitis E virus
-
Wang L, Cao D, Wei C, Meng XJ, Jiang X, Tan M: A dual vaccine candidate against norovirus and hepatitis E virus. Vaccine 2013.
-
(2013)
Vaccine
-
-
Wang, L.1
Cao, D.2
Wei, C.3
Meng, X.J.4
Jiang, X.5
Tan, M.6
-
132
-
-
84882844869
-
Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle
-
Anggraeni MR, Connors NK, Wu Y, Chuan YP, Lua LH, Middelberg AP: Sensitivity of immune response quality to influenza helix 190 antigen structure
-
(2013)
Vaccine
, vol.31
, pp. 4428-4435
-
-
Anggraeni, M.R.1
Connors, N.K.2
Wu, Y.3
Chuan, Y.P.4
Lua, L.H.5
Middelberg, A.P.6
-
133
-
-
84886411258
-
Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants
-
Kawano M, Morikawa K, Suda T, Ohno N, Matsushita S, Akatsuka T, Handa H, Matsui M: Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants. Virology 2014, 448:159-167.
-
(2014)
Virology
, vol.448
, pp. 159-167
-
-
Kawano, M.1
Morikawa, K.2
Suda, T.3
Ohno, N.4
Matsushita, S.5
Akatsuka, T.6
Handa, H.7
Matsui, M.8
|